In a 30‑year‑old woman with PCOS and insulin resistance who is already doing intermittent fasting, hormone‑cycling diet, and weight training, should I treat her low‑normal 25‑OH‑vitamin D level with supplementation, and will that normalize her mildly elevated TSH?

Should You Supplement Vitamin D in This PCOS Patient?

Yes, supplement vitamin D in this 30-year-old woman with PCOS and low-normal vitamin D levels, but do not expect it to normalize her mildly elevated TSH—vitamin D primarily improves insulin resistance and metabolic parameters in PCOS, not thyroid function.

Rationale for Vitamin D Supplementation

The 2024 Endocrine Society guideline on vitamin D does not specifically address PCOS as a target population for empiric supplementation 1. However, your patient has high-risk prediabetes (given her insulin resistance), which is one of the populations for whom the guideline suggests empiric vitamin D supplementation 1.

Evidence Supporting Vitamin D in PCOS with Insulin Resistance

Multiple high-quality randomized controlled trials demonstrate that vitamin D supplementation provides significant metabolic benefits specifically in PCOS women with insulin resistance or obesity:

• A 2024 RCT (the most recent evidence) showed that 2000 IU/day vitamin D for 12 weeks significantly reduced insulin concentrations, HOMA-IR, triglycerides, total cholesterol, and LDL-C in PCOS women—but these benefits were only seen in the obese and insulin-resistant subgroups 2. Non-obese and non-insulin-resistant women showed no metabolic improvement 2.

• A 2020 systematic review of RCTs from 2016-2019 found that high-dose vitamin D (4000 IU) for at least 12 weeks improved glucose levels, insulin sensitivity, lipid profiles, and hormonal function (testosterone, SHBG, FAI) in PCOS women 3.

• A 2019 Iranian trial using a single 300,000 IU intramuscular dose demonstrated significant decreases in fasting glucose (109.6→103.7 mg/dL), fasting insulin (8.52→7.07 μIU/mL), and HOMA-IR (2.37→1.87) 4.

• A 2026 meta-analysis confirmed that lower serum vitamin D correlates significantly with greater insulin resistance in PCOS (pooled r = -0.32), with stronger associations in overweight/obese women (r = -0.35) 5.

Recommended Dosing Strategy

Based on the evidence hierarchy:

Start with 2000-4000 IU daily for 12 weeks minimum 2, 3. The 2020 review specifically noted that high doses (4000 IU) showed superior benefits on metabolic and hormonal parameters compared to lower doses 3.

• If she has documented vitamin D deficiency (<20 ng/mL), consider loading with 50,000-60,000 IU weekly for 8-12 weeks, then maintenance 6
• Recheck 25(OH)D levels after 12 weeks to ensure adequacy
• Continue supplementation long-term given her metabolic risk profile

Will Vitamin D Normalize Her TSH?

No evidence supports vitamin D supplementation for normalizing mildly elevated TSH in PCOS. The provided evidence focuses exclusively on metabolic, hormonal, and reproductive outcomes—none address thyroid function 2, 3, 4, 6, 5, 7.

Her mildly elevated TSH requires separate evaluation:

• Check thyroid peroxidase antibodies (TPO-Ab) to rule out autoimmune thyroiditis
• Recheck TSH and free T4 in 6-8 weeks
• Consider thyroid hormone replacement if TSH remains elevated with symptoms or if trying to conceive

Integration with Her Current Regimen

Her intermittent fasting, hormone-cycling diet, and weight training are excellent first-line approaches that align with guideline recommendations 8, 9. The 2020 Endocrine Society lipid guideline emphasizes that lifestyle changes are first-line therapy for PCOS metabolic dysfunction 8.

Vitamin D supplementation complements but does not replace lifestyle modification. The evidence shows vitamin D works synergistically with weight management to improve insulin resistance 2, 10.

Additional Metabolic Screening

Since you're already addressing insulin resistance, ensure you've completed the recommended PCOS metabolic workup 8, 9:

• Fasting lipid panel (dyslipidemia occurs in up to 70% of US PCOS women) 8
• 2-hour 75g oral glucose tolerance test with insulin levels (not just fasting glucose—40-45% of PCOS women have IGT or T2DM) 11, 9
• Calculate HOMA-IR to quantify insulin resistance severity
• Screen for obstructive sleep apnea if she has symptoms 8

Common Pitfalls to Avoid

1. Don't use vitamin D as monotherapy for insulin resistance—it augments but doesn't replace lifestyle modification 2, 10

2. Don't expect universal benefit—the metabolic improvements are most pronounced in women with obesity or established insulin resistance 2, 12

3. Don't use low doses—studies showing benefit used 2000-4000 IU daily or equivalent loading doses 3, 4, 6

4. Don't conflate vitamin D's metabolic benefits with thyroid effects—these are separate issues requiring separate management

5. Don't forget contraception counseling—if you later add metformin (second-line after lifestyle modification per guidelines 13), she needs reliable contraception as improved ovulation may occur 13

Bottom Line Algorithm

For this patient:

1. ✓ Start vitamin D 2000-4000 IU daily (she has insulin resistance, making her a candidate)
2. ✓ Continue her lifestyle interventions (first-line therapy)
3. ✓ Complete metabolic screening (lipids, OGTT with insulin)
4. ✓ Separately evaluate her TSH (check TPO-Ab, recheck in 6-8 weeks)
5. ✓ Consider metformin if lifestyle + vitamin D insufficient for metabolic control after 3-6 months 13

The vitamin D will likely improve her insulin resistance and lipid profile but won't fix her thyroid—address both issues independently.